Drugs Against Calcitonin Gene-Related Peptide and its Receptor Used in the Treatment of Migraine: What are the New Progresses?
Journal Title: Neuro – Open Journal - Year 2015, Vol 2, Issue 3
Abstract
Migraine is a chronic headache disorder that its exact pathomechanism is not very well known but research in the last two decades indicates that it might be a brain disorder, a dismodulation of sensory processing of the brainstem responsible for regulation of vascular tone and the pain. Several neurotransmitters and neuromodulators including neuropeptides have been implicated in the pathomechanism of migraine, among them, Calcitonin gene-related peptide (CGRP) has been the focus of many studies in recent years. Increased CGRP level (perhaps due to release from peripheral and central sensory nerve endings) has been detected in the blood of migraine patients and many basic and clinical investigators in recent years have been trying to block the CGRP receptor by means of newly developed CGRP-receptor antagonist drugs or inhibit its activity by even newer compounds, the monoclonal Antibodies (mAbs) against CGRP or its receptor. These latter ones are still in clinical trials but have had promising results so far in alleviating the pain of migraine patients. This article will briefly review and discuss the role of CGRP and its receptor in migraine and some of the other biological activities of CGRP, the CGRP receptor antagonist drugs and the new progresses in mAbs against CGRP or its receptor.
Authors and Affiliations
Mohtashem Samsam
Keywords
Related Articles
- EP ID EP552577
- DOI 10.17140/NOJ-2-117
- Views 121
- Downloads 0
Adult Attention-Deficit and Hyperactivity Disorder and Fibromyalgia: A Case-Control Study
Introduction: Fibromyalgia syndrome (FMS) is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. An association between attention deficit and fibromyalgia wa...
Lipocalin-2 in Stroke
Stroke is a leading cause of adult disability in the United States. However, limited number of molecularly targeted therapy exists for stroke. Recent studies have shown that Lipocalin-2 (LCN2) is an acute phase protein m...
Chronic Subdural Haematoma: Systematic Review Highlighting Risk Factors for Recurrent Bleeds
Introduction: Chronic subdural haematoma (CSDH) is one of the commonest forms of intracranial haemorrhage. Surgical drainage of CSDH is a routine operation in the modern neurosurgical practice which has shown to be the m...
An Unusual Intracranial Inflammatory Process of Unknown Origin
We present an unusual case of steroid responsive inflammatory condition, involving sellar suprasellar region with further ependymal lesions. This is complicated by previous surgery due to pituitary adenoma, not thought t...
Gaucher’s Disease, Myoclonic Seizures after Splenectomy: A Case Report
Gaucher’s Disease (GD) is the most prevalent lysosomal storage disorder, resulting from the accumulation of glucocerebrosidase in the cells of macrophagemonocyte system due to a deficiency in lysosomal glucocerebrosidase...